Piermont Capital Management Inc. - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 162 filers reported holding ANIKA THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.

Quarter-by-quarter ownership
Piermont Capital Management Inc. ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q4 2018$1,343,000
-18.7%
39,950
+2.0%
0.64%
-3.8%
Q3 2018$1,651,000
+14.3%
39,150
-13.2%
0.66%
+49.8%
Q2 2018$1,444,000
-33.0%
45,124
+4.2%
0.44%
-38.5%
Q1 2018$2,154,000
+4.4%
43,324
+13.2%
0.72%
+6.2%
Q4 2017$2,064,000
-10.6%
38,284
-3.9%
0.68%
-11.5%
Q3 2017$2,310,000
+17.6%
39,8240.0%0.76%
+36.1%
Q2 2017$1,965,000
-9.5%
39,824
-20.4%
0.56%
+8.5%
Q1 2017$2,172,000
-17.1%
50,000
-6.6%
0.52%
-13.5%
Q4 2016$2,621,000
-4.1%
53,535
-6.3%
0.60%
-7.4%
Q3 2016$2,734,000
-36.7%
57,139
-29.0%
0.65%
-42.1%
Q2 2016$4,318,000
+604.4%
80,488
+487.5%
1.12%
+469.9%
Q1 2016$613,000
+14.8%
13,700
-2.1%
0.20%
+15.3%
Q4 2015$534,000
+10.1%
14,000
-8.1%
0.17%
+7.6%
Q3 2015$485,000
-3.6%
15,2400.0%0.16%
+3.9%
Q2 2015$503,000
-22.4%
15,240
-3.2%
0.15%
-22.8%
Q1 2015$648,000
+53.2%
15,740
+51.6%
0.20%
+31.3%
Q4 2014$423,000
+9.6%
10,380
-1.3%
0.15%0.0%
Q3 2014$386,000
+43.0%
10,520
+80.4%
0.15%
+42.9%
Q2 2014$270,000
+12.5%
5,8300.0%0.10%
-9.5%
Q1 2014$240,000
+8.1%
5,8300.0%0.12%
+4.5%
Q4 2013$222,0005,8300.11%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Caligan Partners LP 1,081,360$20,145,7379.25%
Trigran Investments, Inc. 2,217,019$41,303,0654.40%
DIKER MANAGEMENT LLC 50,239$935,9530.84%
Virtus Investment Advisers, Inc. 45,579$849,1370.58%
Virtus Fund Advisers, LLC 3,490$65,0190.46%
CAPITAL MANAGEMENT CORP /VA 84,225$1,569,1120.35%
Riverwater Partners LLC 17,597$327,8320.30%
BOOTHBAY FUND MANAGEMENT, LLC 617,602$11,505,9250.27%
XTX Topco Ltd 28,033$522,2550.09%
GSA CAPITAL PARTNERS LLP 51,638$9620.08%
View complete list of ANIKA THERAPEUTICS INC shareholders